Live from the NIH registry
Studies recruiting near Nampa right now
Top 25 of 261 recruiting studies, sorted by proximity — each links to its official registry page
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
St. Lukes — Boise, Idaho (18.1 mi)
· Sponsor: Giselle Sholler
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (18.1 mi)
· Sponsor: Sameek Roychowdhury
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Treasure Valley Medical Research — Boise, Idaho (18.1 mi)
· Sponsor: Celldex Therapeutics
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Saint Luke's Cancer Institute - Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Boise, Idaho Investigative Site 10073 — Boise, Idaho (18.1 mi)
· Sponsor: Colorado Prevention Center
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Paradigm Clinical Research - Boise, ID — Boise, Idaho (18.1 mi)
· Sponsor: Sparrow Pharmaceuticals
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: NRG Oncology
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Saint Alphonsus Medical Center — Nampa, Idaho (3.0 mi)
· Sponsor: Pfizer
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
Humphreys Diabetes Center — Boise, Idaho (18.1 mi)
· Sponsor: Pfizer
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Direct Biologics, LLC
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
St. Luke's Children's Endocrinology — Boise, Idaho (18.1 mi)
· Sponsor: BioMarin Pharmaceutical
A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults
Adult, Healthy Participants
Phase 3
Interventional 600 participants sought
Solaris Clinical Research — Meridian, Idaho (8.8 mi)
· Sponsor: Pfizer
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.8 mi)
· Sponsor: Novo Nordisk A/S
ASSESS ALL ALS Study
Amyotrophic Lateral Sclerosis
N/A
Observational 2,000 participants sought
Saint Alphonsus Regional Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Ada West Research — Meridian, Idaho (8.8 mi)
· Sponsor: LEO Pharma
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
St Luke's Clinic - Neurology — Meridian, Idaho (8.8 mi)
· Sponsor: Pfizer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Amgen
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Treasure Valley Medical Research — Boise, Idaho (18.1 mi)
· Sponsor: Incyte Corporation
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Saint Alphonsus Regional Medical Center ( Site 0085) — Boise, Idaho (18.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 180 participants sought
Saint Alphonsus Health System — Boise, Idaho (18.1 mi)
· Sponsor: Nuvation Bio Inc.